Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
The Journal of Infectious Diseases|November 14, 2012
Impact of UGT1A1 Gilbert variant on discontinuation of ritonavir-boosted atazanavir in AIDS Clinical Trials Group Study A5202Heather J Ribaudo, Eric S Daar, Camlin Tierney, et al.
JMIR Formative Research|April 19, 2022
Development of a Blended Learning Approach to Delivering HIV-Assisted Contact Tracing in Malawi: Applied Theory and Formative ResearchNora Ellen Rosenberg, Tapiwa A Tembo, Katherine R Simon, et al.
The Journal of Infectious Diseases|November 14, 2012
HIV-1 amino acid changes among participants with virologic failure: associations with first-line efavirenz or atazanavir plus ritonavir and disease statusKatie Mollan, Eric S Daar, Paul E Sax, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2014
Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202Charles S Venuto, Katie Mollan, Qing Ma, et al.
Journal of Clinical Pharmacology|December 18, 2013
Expression of six drug transporters in vaginal, cervical, and colorectal tissues: Implications for drug disposition in HIV preventionMelanie R Nicol, Yuri Fedoriw, Michelle Mathews, et al.
Antiviral Therapy|August 12, 2015
Antiretroviral activity and safety of once-daily etravirine in treatment-naive HIV-infected adults: 48-week resultsMichelle A Floris-Moore, Katie Mollan, Aimee M Wilkin, et al.
AIDS Care|September 17, 2025
Contraceptive method continuation among a prospective cohort study of Malawian women on antiretroviral treatment initiating the Levonorgestrel Implant or the Depot Medroxyprogesterone Acetate Injectable for pregnancy prevention (the FP-ART study)Jill Hagey, Xingyan Liu, Katie Mollan, et al.
BMJ Global Health|March 13, 2026
Effect of a digital training package on clinical outcomes in Malawi's index case testing programme: a cluster randomised controlled trialNora Rosenberg, Katie Mollan, Jiayu Wang, et al.
Antiviral Therapy|February 10, 2018
Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015Angela M Bengtson, Brian W Pence, Ellen F Eaton, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 21, 2013
Outcomes by sex following treatment initiation with atazanavir plus ritonavir or efavirenz with abacavir/lamivudine or tenofovir/emtricitabineKimberly Y Smith, Camlin Tierney, Katie Mollan, et al.
Pageof 4